9todozen.com 9todozen.com 9todozen.com
Search:    Home >> About Us >> Privacy >> Terms of Service >> Add Url >> Add Article   
 
 

Affidavits Are Also Affirmations

Affidavit is both a legal and moral piece of document. The value of affidavit can add or diminish a ... - Michael Colucci
 

A Good Lemon Law Lawyer To Take You All The Way

A lemon law lawyer is the best person around to consult. He is the one to guide you through the enti ... - Kevin Bishop
 

Juvenile Offenders and Troubled Teens

A "delinquent" is defined as under the age of majority who has been convicted in juvenile court of s ... - Harry Johnson
 

Estate Planning - No Contest Clause in your Will

Over views the consideration of putting a no contest clause into one??s will if they feel the will i ... - Ronald Hudkins
 

What Does A Criminal Attorney Do?

You may have seen tv shows where criminal attorneys make their case for a defendant. What is it that ... - John Williams
 

Estate Planning - Changing A Will

Over views the legal complications that could result in changing a last will and testament without d ... - Ronald Hudkins
 
 

Home –› Policies & Law –› Govt Laws
 

Patenting and Database Controversies --- Does the One with the Most Sequence Really Win?

 

Author: Aaron Hall
Rebecca Eisenberg (University of Michigan Law School) raised intriguing questions about the proper roles of government and industry in genomic research. One consideration is who stands to benefit (and to lose) rom the private appropriation of genomic information. Controversy, she noted, is particularly acute over the intellectual property rights in large-scale cDNA sequencing data.

Genomics research involves a major commitment of both federal and private funds, and both groups have an interest in making use of the wealth of new discoveries, she noted. In addition, the implications for human health make public access crucial. Access also affects the interests of the young biotechnology industry, as well as the more established pharmaceutical companies. Eisenberg analyzed possible motivations behind recent steps taken by Merck & Co., Human Genome Sciences, and Incyte to develop databases of human gene sequences. The take-home lesson, she concluded, may be that the value of a rich public domain to both the public and private sectors has been underestimated

Author Bio:

You can also reach this article by using: branch of government makes laws, which branch of government makes the laws
 
 
 

Related Articles

 
Terrorism - Just Say No!
 
How to Send Care Packages to Troops Overseas
 
Employment Law: Time Limits for Bringing Employment Tribunal Claims
 
Juvenile Offenders and Troubled Teens
 
What shows up on a criminal record background check?
 
Patenting and Database Controversies --- Does the One with the Most Sequence Really Win?
 
Lawsuit Cash Advances - Things to Consider
 
Ohio Private Investigators
 
Georgia Injury Lawyers
 
Patent - Business Method Patents - Part II
 
 
 
Add Url
 

Entertainment

Healthcare & Medicine

Banking & Finance

Fashion & Relationships

Computers & Software

Education & Reference

Online Shopping

Policies & Law

Jobs & Careers

Children

Home & Garden

Vehicles & Automotive

Technology & Science

Business & Services

Creative Arts

Health & Hygiene

Issues & News

People & Communities

Food & Recipe

Adventure & Sports

Estate & Realty

Travel & Accommodation

Self Management

Online & Board Games


 
Home >> Privacy >> Terms of Service  
© 2008 www.9todozen.com All Rights Reserved.